Genome-wide association meta-analysis identifies pleiotropic risk loci for aerodigestive squamous cell cancers
- PMID: 33667223
- PMCID: PMC7968735
- DOI: 10.1371/journal.pgen.1009254
Genome-wide association meta-analysis identifies pleiotropic risk loci for aerodigestive squamous cell cancers
Abstract
Squamous cell carcinomas (SqCC) of the aerodigestive tract have similar etiological risk factors. Although genetic risk variants for individual cancers have been identified, an agnostic, genome-wide search for shared genetic susceptibility has not been performed. To identify novel and pleotropic SqCC risk variants, we performed a meta-analysis of GWAS data on lung SqCC (LuSqCC), oro/pharyngeal SqCC (OSqCC), laryngeal SqCC (LaSqCC) and esophageal SqCC (ESqCC) cancers, totaling 13,887 cases and 61,961 controls of European ancestry. We identified one novel genome-wide significant (Pmeta<5x10-8) aerodigestive SqCC susceptibility loci in the 2q33.1 region (rs56321285, TMEM273). Additionally, three previously unknown loci reached suggestive significance (Pmeta<5x10-7): 1q32.1 (rs12133735, near MDM4), 5q31.2 (rs13181561, TMEM173) and 19p13.11 (rs61494113, ABHD8). Multiple previously identified loci for aerodigestive SqCC also showed evidence of pleiotropy in at least another SqCC site, these include: 4q23 (ADH1B), 6p21.33 (STK19), 6p21.32 (HLA-DQB1), 9p21.33 (CDKN2B-AS1) and 13q13.1(BRCA2). Gene-based association and gene set enrichment identified a set of 48 SqCC-related genes rel to DNA damage and epigenetic regulation pathways. Our study highlights the importance of cross-cancer analyses to identify pleiotropic risk loci of histology-related cancers arising at distinct anatomical sites.
Conflict of interest statement
I have read the journal’s policy and the authors of this manuscript have the following competing interests. Dr. Ferris has the following financial disclosures: Aduro Biotech, Inc (consulting); Astra-Zeneca/MedImmune (clinical trial, research funding); Bristol-Myers Squibb (advisory board, clinical trial, research funding); EMD Serono (advisory board); MacroGenics, Inc (advisory board); Merck (advisory board, clinical trial); Novasenta (consulting, stock, research funding); Numab Therapeutics AG (advisory board); Pfizer (advisory board); Sanofi (consultant); Tesaro (research funding) and Zymeworks, Inc (consultant). All other authors have no conflicts to disclose.
Figures
References
Publication types
MeSH terms
Substances
Grants and funding
- RP-PG-0707-10034/DH_/Department of Health/United Kingdom
- P30 CA047904/CA/NCI NIH HHS/United States
- P50 CA119997/CA/NCI NIH HHS/United States
- R01 DE025712/DE/NIDCR NIH HHS/United States
- R01 CA090731/CA/NCI NIH HHS/United States
- P30 CA076292/CA/NCI NIH HHS/United States
- U01 CA063464/CA/NCI NIH HHS/United States
- UL1 TR000117/TR/NCATS NIH HHS/United States
- P20 CA090578/CA/NCI NIH HHS/United States
- U19 CA148127/CA/NCI NIH HHS/United States
- UL1 TR000445/TR/NCATS NIH HHS/United States
- R01 CA092824/CA/NCI NIH HHS/United States
- UM1 CA164973/CA/NCI NIH HHS/United States
- U01 CA167462/CA/NCI NIH HHS/United States
- U19 CA203654/CA/NCI NIH HHS/United States
- P20 RR018787/RR/NCRR NIH HHS/United States
- S10 RR025141/RR/NCRR NIH HHS/United States
- R01 CA074386/CA/NCI NIH HHS/United States
- R01 CA176568/CA/NCI NIH HHS/United States
- K07 CA172294/CA/NCI NIH HHS/United States
- R01 CA063464/CA/NCI NIH HHS/United States
- P01 CA033619/CA/NCI NIH HHS/United States
- P30 CA177558/CA/NCI NIH HHS/United States
- P50 CA097190/CA/NCI NIH HHS/United States
- P50 CA090578/CA/NCI NIH HHS/United States
- P50 CA070907/CA/NCI NIH HHS/United States
- S10 OD025092/OD/NIH HHS/United States
- U01 HG004798/HG/NHGRI NIH HHS/United States
- R01 CA151989/CA/NCI NIH HHS/United States
- UM1 CA167462/CA/NCI NIH HHS/United States
- 001/WHO_/World Health Organization/International
- U01 CA164973/CA/NCI NIH HHS/United States
- R01 CA111703/CA/NCI NIH HHS/United States
- CRUK_/Cancer Research UK/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous
